Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs methylprednisolone injection for partial rotator cuff tear
IRCT20230608058415N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of platelet-rich plasma and methylprednisolone in partial-thickness rotator cuff tear (PRCT) (2 arms), sponsored by Tehran University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
platelet-rich plasmamethylprednisolone
03
Conditions
partial-thickness rotator cuff tear (PRCT)
Beyond the preview
Go deeper on IRCT20230608058415N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230608058415N1.